The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 02, 2025 for Raksha Sudhir Valia
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts less than Nifty 100 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Raksha Sudhir Valia, a Person Acting in Concert with the promoters of Sun Pharmaceutical Industries, has created a pledge on 6,50,000 equity shares (about 0.027% of total share capital) on July 28, 2025. The pledge is in favor of Citicorp Finance (India) Limited as security for a loan facility availed by a third party. Post this pledge, Raksha Valia's encumbered shares rise from 11,990,000 (0.499%) to 12,640,000 (0.527%) of total share capital. Her total holding in Sun Pharma stands at 28,830,352 shares (1.20%). This is a routine regulatory disclosure required when promoters or PACs create encumbrances on their shares.
Minimal impact on shareholders — the pledged quantity is very small (0.027% of total capital) and the pledge is for a third-party loan, not for the company itself. The overall promoter/PAC group remains well above 50% in Sun Pharma, so no change in control concerns arise.